...
首页> 外文期刊>Lab on a chip >Biodegradable microcontainers - towards real life applications of microfabricated systems for oral drug delivery
【24h】

Biodegradable microcontainers - towards real life applications of microfabricated systems for oral drug delivery

机译:可生物降解的微肠器 - 朝着用于口服药物递送的微制定系统的现实寿命应用

获取原文
获取原文并翻译 | 示例
           

摘要

Microfabrication techniques have been applied to develop micron-scale devices for oral drug delivery with a high degree of control over size, shape and material composition. Recently, microcontainers have been introduced as a novel approach to obtain unidirectional release to avoid luminal drug loss, enhance drug permeation, protect drug payload from the harsh environment of the stomach, and explore the ability for targeted drug delivery. However, in order to eventually pave the way for real life applications of these microfabricated drug delivery systems, it is necessary to fabricate them in biodegradable materials approved for similar applications and with strategies that potentially allow for large scale production. In this study, we for the first time evaluate biodegradable microcontainers for oral drug delivery. Asymmetric poly-epsilon-caprolactone (PCL) microcontainers with a diameter of 300 mu m and a volume of 2.7 nL are fabricated with a novel single-step fabrication process. The microcontainers are loaded with the model drug paracetamol and coated with an enteric pH-sensitive Eudragit (R) S100 coating to protect the drug until it reaches the desired location in the small intestine. In vitro dissolution studies are performed to assess the drug load and release profile of the PCL microcontainers. Finally, in vivo studies in rats showed a higher bioavailability compared to conventional dosage forms and confirm the potential of biodegradable microcontainers for oral drug delivery.
机译:已经应用微型制造技术来开发用于口服药物递送的微米级装置,具有高度的控制尺寸,形状和材料组合物。最近,微肠道被引入作为获得单向释放的新方法,以避免腔内损失,增强药物渗透,保护药物有效载荷免受胃部的恶劣环境,并探讨靶向药物递送的能力。然而,为了最终为这些微制订药物递送系统的现实寿命应用铺平道路,必须以可用于类似应用的可生物降解材料和可能允许大规模生产的策略制造它们。在这项研究中,我们首次评估可生物降解的微肠道以进行口服药物递送。具有直径为300μm和体积为2.7nl的微囊的不对称聚ε-己内酯(PCL)微肠器用新型单步制造工艺制造。微肠器用模型药物扑热息醇加载并涂有肠溶pH敏感的Eudragit(R)S100涂层以保护药物直至其达到小肠中所需的位置。进行体外溶解研究以评估PCL微肠道的药物载荷和释放曲线。最后,与常规剂型相比,大鼠的体内研究表现出更高的生物利用度,并确认可生物降解的微肠蛋白用于口服药物递送的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号